Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2007, Vol. 12 ›› Issue (4): 381-384.

Previous Articles     Next Articles

Effects of maslinic acid as a novel glycogen phosphorylase inhibitor on cerebral ischemia in mice

GUAN Teng1, LI Yun-man1, SUN Hong-bin2   

  1. 1Department of Physiology;2Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, Jiangsu,China
  • Received:2006-12-12 Revised:2006-12-12 Published:2020-10-30

Abstract: AIM: This experiment was designed to study the protective effects of maslinic acid, a novel glycogen phosphorylase inhibitor, on cerebral ischemia in mice. METHODS: The model of acute cerebral ischemia-reperfusion in mice was set up by ligating bilateral common carotid artery and vagus, thus blocking the blood stream for 90 s, and subjecting mice to 5 min reperfusion.Brain samples were prepared to observe the cerebral injury;liver samples were prepared to observe the status of hepatic glucose metabolism, which contribute to the observed hyperglycemia during cerebral ischemia. RESULTS: Maslinic acid significantly reduced the lactate and MDA level, increased SOD and LDH activity and preserved the hepatic glycogen after mice were subjected to acute cerebral ischemia-reperfusion. CONCLUSION: Maslinic acid may exert its potential protective effects against cerebral ischemic injury, at least in part, through inhibition of over degradation of cerebral glycogen and thus reducing/Lactate production during ischemia.

Key words: cerebral ischemia, ischemia-reperfusion injury, lactate acidosis, glycogen phosphorylase inhibitors, maslinic acid

CLC Number: